Skin Basal Cell Carcinoma — Trials

Skin Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 11
Ph III recruiting: 2
Growth YoY: —
Industry share: 29%
Top sponsor: University of Rochester
Termination share: 10%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01808950	Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma	terminated	Phase 1 / Phase 2	4	Spirig Pharma Ltd.INDUSTRY	2	Jun 22, 2016	clinicaltrials
NCT00994240	Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC	terminated	N/A	85	University of Wisconsin, MadisonOTHER	1	Feb 27, 2015	clinicaltrials